Posted on 7/29/16
RELiZORB Recognized for Medical Design Excellence
Alcresta Therapeutics, Inc. (Alcresta), a company focused on developing innovative enzyme-based products for gastrointestinal and rare diseases, today announced that RELiZORB was selected as the Gold . . .
Posted on 7/29/16
BenefitMall Partners with Maryland Health Benefit Exchange
BenefitMall®, a leading provider of employee benefits and payroll services, has been chosen as the administrator of the small business health insurance program offered through Maryland's state-based . . .
Posted on 7/28/16
Alkermes Reports Second Quarter 2016 Financial Results
DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today reported financial results for the second quarter of 2016. “Our second quarter results demonstrate the power of our business model . . .
Posted on 7/29/16
NKF-MD Bringing Free Kidney Health Assessment to Restoration Community Ministries, Aug. 6
The National Kidney Foundation of Maryland (NKF-MD) will bring its Kidney Health Risk Assessment (KHRA) to the Baltimore Urban Leadership Foundation & Restoration Community Ministries Annual Fun . . .
Posted on 7/28/16
University of Maryland Ventures Appoints Darryl L. Carter, MD, as Venture Advisor
Today, University of Maryland (UM) Ventures announced the appointment of Darryl L. Carter, MD, co-founder and
Posted on 7/29/16
CCAH Signs Phoenix Children’s Hospital Foundation
Direct Mail and Digital Marketing Services Will Further the Foundation’s Work on Behalf of Phoenix Children’s Hospital CCAH, a full-service direct marketing firm serving global nonprofit . . .
Posted on 7/28/16
United Therapeutics Corporation Reports Second Quarter 2016 Financial Results
United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2016."We are pleased with our second quarter 2016 financial . . .
Posted on 7/28/16
Key Takeaways From Johnson & Johnson's Q2 Earnings Report
Pharmaceutical giant?Johnson & Johnson?(NYSE:JNJ) reported its second-quarter financials earlier this week and results outpaced industry watchers' forecast on both the top and the bottom line. After . . .
Posted on 7/28/16
Why Anavex Life Sciences Corp. Just Imploded
IMAGE SOURCE: GETTY IMAGES.What: Shares of Anavex Life Sciences (NASDAQ:AVXL), a clinical-stage biotech company focused on the development of drug candidates to treat Alzheimer's disease and . . .
Posted on 7/27/16
Anika Reports Second Quarter 2016 Financial Results
BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today reported . . .
Posted on 7/27/16
Vertex Reports Second Quarter 2016 Financial Results
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the quarter ended June 30, 2016 and reviewed recent progress with its approved and . . .
Posted on 7/27/16
Vanda Pharmaceuticals Reports Second Quarter 2016 Financial Results
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial and operational results for the second quarter ended June 30, 2016."Vanda's commercial business continues to demonstrate strong . . .
Posted on 7/27/16
Nevakar Announces $55 Million Fundraising
Nevakar LLC, a privately-held specialty pharmaceutical company developing innovative products focused on therapies within
Posted on 7/27/16
Frontage Laboratories Announces Formation of FJ Pharma a Joint Venture with Zhejiang Jiuzhou Pharmaceutical Co
EXTON, Pa.--(BUSINESS WIRE)--Today, Frontage Laboratories, Inc. announced that it has established a joint venture with Zhejiang Jiuzhou Pharmaceutical Co., Ltd. to provide enhanced access to high . . .
Posted on 7/27/16
Data Diagnostics Healthcare Technology Wins Two Gold Honors for Innovation in the 2016 Golden Bridge Awards
Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) today announced that Data Diagnostics™, a point-of-care health analytics technology, has won two gold medals at the 2016 . . .
Posted on 7/27/16
The Medicines Company Reports Second-Quarter 2016 Business and Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced its business and financial results for the second quarter ended June 30, 2016.During the second quarter of 2016, . . .
Posted on 7/27/16
IMS Health Reports Second-Quarter 2016 Results
DANBURY, Conn.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced results for . . .
Posted on 7/27/16
Kevin Bernard, MD Joins New England Baptist Hospital
Kevin Bernard, MD has joined New England Baptist Hospital, a Boston-based premier regional provider for orthopedic surgery
Posted on 7/27/16
Avitide to Expand Affinity Separation Discovery and Manufacturing Operations
LEBANON, N.H.--(BUSINESS WIRE)--Avitide, Inc., a biotech company dedicated to the discovery, manufacture, and supply of on-demand affinity purification solutions for the biopharmaceutical industry, announced that it . . .
Posted on 7/27/16
Universal Health Services Reports 2016 Second Quarter Financial Results
Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $185.6 million, or $1.89 per diluted share, during the . . .
Posted on 7/27/16
Kadmon Prices IPO
NEW YORK--(BUSINESS WIRE)--Kadmon Holdings, Inc. today announced the pricing of its initial public offering of 6,250,000 shares of common stock at $12.00 per share, before underwriting . . .
Posted on 7/27/16
Bristol-Myers Squibb Announces New Research Collaboration with Janssen in Immuno-Oncology Focused on Lung Cancer
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced a new clinical research collaboration with Janssen Biotech, Inc. to evaluate Bristol-Myers Squibb’s Immuno-Oncology (I-O) agent Opdivo(nivolumab) and . . .
Posted on 7/27/16
Cynosure Reports Net Income of $6.3 Million for Q2 2016
Cynosure, Inc. (NASDAQ: CYNO) today reported second-quarter 2016 net income of $6.3 million, or $0.27 per diluted share, an increase of 18.3 percent compared with$5.4 million, . . .
Posted on 7/26/16
Psychemedics Corp. Announces Record Revenues And Earnings
Psychemedics Corporation (NASDAQ: PMD) today announced second quarter financial results for the period ended June 30, 2016. The Company also announced a quarterly dividend of $0.15 . . .
Posted on 7/26/16
Tokai Pharmaceuticals Announces Clinical Update
BOSTON--(BUSINESS WIRE)--Tokai Pharmaceuticals Inc. (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced that . . .
